These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25970343)

  • 1. Calprotectin and platelet aggregation in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Pareek M; Kristensen SD; Hvas AM
    PLoS One; 2015; 10(5):e0125992. PubMed ID: 25970343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    PLoS One; 2015; 10(5):e0126767. PubMed ID: 25993271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin and platelet aggregation in patients with stable coronary artery disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    Platelets; 2017 Dec; 28(8):822-824. PubMed ID: 28436258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced antiplatelet effect of aspirin during 24 hours in patients with coronary artery disease and type 2 diabetes.
    Christensen KH; Grove EL; Würtz M; Kristensen SD; Hvas AM
    Platelets; 2015; 26(3):230-5. PubMed ID: 24750015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease.
    Grove EL; Hvas AM; Mortensen SB; Larsen SB; Kristensen SD
    J Thromb Haemost; 2011 Jan; 9(1):185-91. PubMed ID: 20955349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease.
    Würtz M; Grove EL; Kristensen SD; Hvas AM
    Heart; 2010 Mar; 96(5):368-71. PubMed ID: 19910291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet aggregation and serum thromboxane levels in aspirin-treated patients with prior myocardial infarction.
    Larsen SB; Neergaard-Petersen S; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2012 Jul; 108(1):140-7. PubMed ID: 22534977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets.
    Würtz M; Grove EL; Wulff LN; Kaltoft AK; Tilsted HH; Jensen LO; Hvas AM; Kristensen SD
    JACC Cardiovasc Interv; 2010 Aug; 3(8):828-35. PubMed ID: 20723855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin in coronary artery disease: an appraisal of functions and limitations.
    Würtz M
    Dan Med J; 2015 Apr; 62(4):B5011. PubMed ID: 25872543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation is dependent on platelet count in patients with coronary artery disease.
    Würtz M; Hvas AM; Kristensen SD; Grove EL
    Thromb Res; 2012 Jan; 129(1):56-61. PubMed ID: 21917303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.
    Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL
    Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Haemoglobin A1c Levels on Platelet Aggregation and Platelet Turnover in Patients with Coronary Artery Disease Treated with Aspirin.
    Neergaard-Petersen S; Hvas AM; Grove EL; Larsen SB; Gregersen S; Kristensen SD
    PLoS One; 2015; 10(7):e0132629. PubMed ID: 26148094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of aspirin resistance in patients with type 2 diabetes.
    Paven E; Dillinger JG; Bal Dit Sollier C; Vidal-Trecan T; Berge N; Dautry R; Gautier JF; Drouet L; Riveline JP; Henry P
    Diabetes Metab; 2020 Oct; 46(5):370-376. PubMed ID: 31783142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic effects of different aspirin dosing regimens in type 2 diabetes mellitus patients with coronary artery disease.
    Capodanno D; Patel A; Dharmashankar K; Ferreiro JL; Ueno M; Kodali M; Tomasello SD; Capranzano P; Seecheran N; Darlington A; Tello-Montoliu A; Desai B; Bass TA; Angiolillo DJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):180-7. PubMed ID: 21386092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.